APOC3 and tuberculosis: Using proteomic technology, Liu et al. [22] established a diagnostic serum proteomic model for the three TCM syndromes in tuberculosis (TB), and ApoC-III was identified as a potential biomarker for TCM syndrome differentiation in TB.